IFPMA Grant to Support TDR’s Development of New Medicines for Neglected Diseases
The USD 1 million IFPMA grant to TDR includes contributions from Abbott, Astellas, Bayer HealthCare, Chugai, Eisai, Merck & Co., Pfizer, Schering-Plough and Takeda.
Press Release (pdf)
TDR (website)